Xenon

home run
Biotech

Xenon epilepsy candidate 'blows away' ph. 3 expectations

Xenon plans to submit azetukalner for FDA approval later this year, and analysts believe it could become the new standard of care.
Darren Incorvaia Mar 9, 2026 10:55am
bullish sentiment

Biotech’s top 5 stock picks for 2026: analyst

Dec 23, 2025 10:05am
fail

Xenon's MDD med fails ph. 2, elevating seizure potential

Nov 27, 2023 10:45am
fight gloves boxing punch ring tape fists

Double whammy for Neurocrine as Takeda, Xenon pacts fail

Nov 10, 2023 7:22am
Graphic of a man on a row boat with a handheld telescope looking off to the distance

Biohaven veers toward Kv7 platform following Pfizer sale

Oct 4, 2022 11:48am
money

Xenon frees itself of some XEN1101 milestone obligations

Sep 11, 2018 9:55am